SBIR/STTR Research Award
Development of a Pan-HIV Proteomic Chip
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ImmPORT Therapeutics Inc dba Antigen Discovery Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- ZJAMPJY7M149
- Solicitation number
- PA13-088
- Topic code
- NIDCR
Research abstract
DESCRIPTION (provided by applicant): HIV-1 causes the largest number of deaths from a single infectious agent in the world today. Despite considerable advances in treatment of HIV-1 infection and AIDS, which it causes, there is an urgent need for better methods of prevention and treatment of HIV-1 infection. The development of a safe and effective vaccine to prevent HIV-1 infection or the subsequent development of AIDS is therefore of the utmost importance. This effort, however, has been hampered by a lackof understanding of the correlates of protective immunity and a lack of the tools needed to measure effective anti-HIV-1 immune responses. We have developed a Multi-Clade HIV-1 Proteomic Chip (MC-HIV-1 chip) that can be used as a tool to rapidly screen antibody responses to HIV-1 elicited in vivo in response to infection or vaccination. The current version of the MC-HIV-1 chip which is available commercially from Antigen Discovery Incorporated (ADI) expresses over 100 HIV-1 proteins, protein fragments
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines
- Optimizing immunogenicity of novel Cryptosporidium vaccine candidates
- SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
- Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis
- Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- RegendoGEL for guided pulp and dentin regeneration
- CraniaMap: Joint Solution for Auto-Segmentation and Landmarking from CBCT Scans
- Improving Caries Diagnosis with Targeted Nanoparticle-Enhanced AI-Assisted Intraoral Imaging
- Epigenetic Compounds Stimulating Dental Bone Repair
- AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care
Research funding history
25 SBIR/STTR records share this UEI (2004–2025). Reported award amounts total $16,715,675. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services